MENU

Jazz Pharmaceuticals (JAZZ) Earnings Date & Reports

A.I. Advisor
published Earnings

JAZZ is expected to report earnings to rise 79.10% to $4.80 per share on July 31

Jazz Pharmaceuticals JAZZ Stock Earnings Reports
Q2'24
Est.
$4.80
Q1'24
Missed
by $1.50
Q4'23
Missed
by $0.16
Q3'23
Missed
by $0.09
Q2'23
Beat
by $0.06
The last earnings report on May 01 showed earnings per share of $2.68, missing the estimate of $4.18. With 35.25K shares outstanding, the current market capitalization sits at 6.84B.
View a ticker or compare two or three
JAZZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Waterloo Road
Phone
+353 16347800
Employees
2800
Web
https://www.jazzpharmaceuticals.com